DKS News

DKS: Summary of financial results for the 2nd quarter (interim period) for the fiscal year ending March 31, 2025 [Japanese GAAP] (consolidated)

Oct 30 01:00 ET

DKS: Notice regarding revisions to consolidated earnings forecasts for the 2nd quarter and full-year consolidated earnings forecasts for the fiscal year ending March 31, 2025, and revisions to dividend forecasts

Aug 28 01:00 ET

DKS: 1st quarter financial results for the March 2025 period (consolidated) based on Japanese standards.

Jul 30 03:00 ET

DKS: Interim report

Jun 28 02:04 ET

DKS: Confirmation letter

Jun 25 03:01 ET

DKS: Securities Report - 160th term (April 1, 2023 to March 31, 2024)

Jun 25 03:00 ET

DKS: Summary of Financial Results for the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Consolidated)

May 14 01:00 ET

Dai-ichi Kogyo Pharmaceutical: Notice regarding revisions to the full-year consolidated earnings forecast for the fiscal year ending March 31, 2024 and dividends (dividends increase) from surplus

Mar 8 00:00 ET

Dai-ichi Kogyo Pharmaceutical: Quarterly Report - 160th Term 3rd Quarter (2023/10/01 - 2023/12/31)

Feb 8 02:00 ET

Daiichi Kogyo Pharmaceutical: Confirmation

Feb 8 02:00 ET

DKS: Summary of Financial Results for the 3rd Quarter Ending March 31, 2024 [Japanese GAAP] (Consolidated)

Jan 30 02:00 ET

DKS: Quarterly Report - 160th Second Quarter (2023/07/01 - 2023/09/30)

Nov 9, 2023 02:00 ET

DKS: Confirmation letter

Nov 9, 2023 02:00 ET

DKS: Notice regarding differences between second quarter consolidated earnings forecasts and actual results and revisions to full-year consolidated earnings forecasts

Oct 30, 2023 01:00 ET

DKS: Summary of Financial Results for the 2nd Quarter Ending March 2024 [Japanese GAAP] (Consolidated)

Oct 30, 2023 01:00 ET

DKS: Confirmation letter

Aug 8, 2023 03:02 ET

DKS: Quarterly Report - First Quarter 160 (2023/04/01 - 2023/06/30)

Aug 8, 2023 03:00 ET

DKS: Summary of Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Consolidated)

Jul 27, 2023 03:00 ET

DKS: Extraordinary Report

Jun 27, 2023 02:02 ET

DKS: Securities Report - 159th Period (2022/04/01 - 2023/03/31)

Jun 23, 2023 03:00 ET